Evidence map›Paper›PMID 35552246›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2022

Rathan M Subramaniam, Fenghai M Duan, Justin Romanoff, Jian Qin Yu, Twyla Bartel, Farrokh Dehdashti, Charles M Intenzo, Lilja Solnes, JoRean Sicks, Brendan C Stack and 1 more

Open access · bronzeAbstract readClinical TrialMulticenter Study
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 5 citations in OpenAlex.

  1. Trial
  2. Article
  3. Diagnostic and Economic Evaluation of [Journal of clinical medicine · 2026
    Article
  4. Article
  5. Head-to-head comparison of [European journal of nuclear medicine and molecular imaging · 2025
    Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 2 countries.

Rathan M SubramaniamOtago Medical School, University of Otago, Otago, Dunedin, New Zealand; rathan.subramaniam@otago.ac.nz.
Fenghai M DuanSchool of Public Health, Brown University, Providence, Rhode Island.
Justin RomanoffSchool of Public Health, Brown University, Providence, Rhode Island.
Jian Qin YuFox Chase Cancer Center, Philadelphia, Pennsylvania.
Twyla BartelGlobal Advanced Imaging, Little Rock, Arkansas.
Farrokh DehdashtiWashington University School of Medicine, St Louis, Missouri.
Charles M IntenzoThomas Jefferson University, Philadelphia, Pennsylvania.
Lilja SolnesJohns Hopkins School of Medicine, Baltimore, Maryland.
JoRean SicksSchool of Public Health, Brown University, Providence, Rhode Island.
Brendan C StackSouthern Illinois School of Medicine, Springfield, Illinois; and.
Val J LoweMayo Clinic, Rochester, Minnesota.
John Brown University · USAdvanced Imaging Research (United States) · USFox Chase Cancer Center · USJohns Hopkins University · USSouthern Illinois University School of Medicine · USThomas Jefferson University · USUniversity of Otago · NZWashington University in St. Louis · USWinnMed · US

Funding

ARRA - ADOPT New Technologies for RDC/CDMSU01CA080098 · NCI · AMERICAN COLLEGE OF RADIOLOGY · PI SCHNALL, MITCHELL D. · 1999 to 2011
$182.7M
Project-006U10CA180820 · NCI · ECOG-ACRIN MEDICAL RESEARCH FOUNDATION · PI Peter J ODwyer · 2014 to 2026
$167.6M
Statistics CoreU10CA180794 · NCI · DANA-FARBER CANCER INST · PI PAUL J CATALANO, CONSTANTINE A. GATSONIS · 2014 to 2026
$111.2M
BIOSTATISTICS DATA MANAGEMENT CENTER FOR ACROINU01CA079778 · NCI · BROWN UNIVERSITY · PI GATSONIS, CONSTANTINE A. · 1999 to 2011
$48.6M
WASHINGTON UNIVERSITY / SITEMAN CANCER CENTER LEAD ACADEMIC SITEUG1CA233339 · NCI · WASHINGTON UNIVERSITY · PI NANCY L BARTLETT, Clifford Grant Robinson · 2019 to 2026
$11.3M
NCI NIH HHS U01 CA079778NCI NIH HHS U01 CA080098NCI NIH HHS U10 CA180794NCI NIH HHS U10 CA180820NCI NIH HHS UG1 CA233339
6 · The paper itself

Abstract

To our knowledge, no prior multicenter clinical trial has reported interobserver agreement of

Indexed as

Fluorodeoxyglucose F18Head and Neck NeoplasmsHumansNeoplasm StagingObserver VariationPositron Emission Tomography Computed TomographyRadiopharmaceuticalsTomography, X-Ray ComputedFluorodeoxyglucose F18RadiopharmaceuticalsFDG PET/CThead and neck canceroncology: head and neckstaging

Identifiers

PMID35552246
PMCPMC9730921
OpenAlexW4280605488

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.